Advanced Liver Fibrosis clinical trials

Explore recruiting advanced liver fibrosis clinical trials.

Recruiting advanced liver fibrosis studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Liver Fibrosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1 open-label positron emission tomography TRIAL to assess changes in liver uptake of [68Ga]Ga-FAPI-46 following oral administration of single doses of AZD2389 to patients with advanced liver fibrosis (PECHORA)

Sweden

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Double-Blind Placebo-Controlled Randomised Phase 1b Study of the Pharmacokinetics of ALE.F02 in Patients with Advanced Liver Fibrosis and/or with Mild Cirrhosis

Slovakia, Romania

Human Pharmacology (Phase I)- Other EU CTIS Study details

An Open-label, Randomized, Three-period, Crossover Study to compare the Pharmacokinetics of GB1211 upon dosing a capsule under fasting condition and a tablet under fasting and fed conditions in healthy volunteers.

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

Advanced Liver Fibrosis trials by city

Advanced Liver Fibrosis clinical trials

Recruiting advanced liver fibrosis studies right now

Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis

Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis

Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis

Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk

Fibrosis Lessens After Metabolic Surgery

A Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients

High Dose Albumin in Refractory Ascites

HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

Efficacy of Simvastatin in Alcoholic Liver Fibrosis

Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease

Comparison of Two sTRAtegies For the Non-Invasive Diagnosis of advanCed Liver Fibrosis in NAFLD

Also recruiting in Europe

A Phase 1 open-label positron emission tomography TRIAL to assess changes in liver uptake of [68Ga]Ga-FAPI-46 following oral administration of single doses of AZD2389 to patients with advanced liver fibrosis (PECHORA)

A Double-Blind Placebo-Controlled Randomised Phase 1b Study of the Pharmacokinetics of ALE.F02 in Patients with Advanced Liver Fibrosis and/or with Mild Cirrhosis

An Open-label, Randomized, Three-period, Crossover Study to compare the Pharmacokinetics of GB1211 upon dosing a capsule under fasting condition and a tablet under fasting and fed conditions in healthy volunteers.

Advanced Liver Fibrosis trials by city

Other conditions